This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:955.)
© 2006 American Heart Association, Inc.

Announcement

Announcement

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Recipients of the 2006 New Investigator Awards

This is the first year of competition for ATVB New Investigator Awards. The Awards are for papers published in ATVB in 2005 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis/Lipoprotein, Thrombosis, and Vascular Biology sections of the journal. The three awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay, and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling.

In the first year of the award, 390 papers were eligible for the Awards.

Ian del Conde, MD, Baylor College of Medicine, received the 2006 Karl Link New Investigator Award in Thrombosis, for his article "Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on Monocytes" (Arterioscler Thromb Vasc Biol. 2005;25;1065–1070).

Heike Methe, MD, Massachusetts Institute of Technology, is the 2006 recipient of the Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins, for his article "Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14+ Monocytes" (Arterioscler Thromb Vasc Biol. . . [Full Text of this Article]